Patent · US Active

Substituted pyrrolizine compounds and uses thereof

US10328053B2 · kind B2 · utility

3Cited by
4References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 25, 2017
Grant dateJun 25, 2019
Priority date
Expiry dateAug 25, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application relates generally to certain substituted pyrrolizine compounds, and pharmaceutical compositions which inhibit HBV replication, and methods of making and using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.